Predicting Pathological Complete Response Following Neoadjuvant Therapy in Patients With Breast Cancer: Development of Machine Learning–Based Prediction Models in a Retrospective Study
Abstract BackgroundBreast cancer is the most prevalent form of cancer worldwide, with 2.3 million new diagnoses in 2022. Recent advancements in treatment have led to a shift in the use of chemotherapy-targeted immunotherapy from a postoperative adjuvant to a preoperative neoad...
Saved in:
| Main Authors: | Chun-Chi Lai, Cheng-Yu Chen, Tzu-Hao Chang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
JMIR Publications
2025-07-01
|
| Series: | JMIR Cancer |
| Online Access: | https://cancer.jmir.org/2025/1/e64685 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Predictive factors of pathological complete response after neoadjuvant therapy for locally advanced rectal cancer
by: LI Hao, LUO Yang, WANG Tingfeng, LIN Haiping, GONG Tingyue, ZHAO Yongheng, ZHONG Ming
Published: (2025-01-01) -
The impact of circWWC3 on neoadjuvant therapy for triple-negative breast cancer and the construction of a nomogram for predicting pathological complete response after neoadjuvant therapy
by: Haoqi Wang, et al.
Published: (2025-07-01) -
Artificial Intelligence‐Based Pathology to Assist Prediction of Neoadjuvant Therapy Responses for Breast Cancer
by: Juan Ji, et al.
Published: (2025-08-01) -
Accuracy of core biopsy image-guided post-neoadjuvant chemotherapy breast to predict pathologic complete response
by: P. V. Krivorotko, et al.
Published: (2022-12-01) -
Evaluation of pathological complete response rates in breast cancer patients undergoing neoadjuvant therapy
by: Gabriella Ferezini Oliveira de Sá, et al.
Published: (2025-05-01)